FDA Approves First Implantable Continuous Glucose Monitor
nnJune 21, 2018nnnnnnnnnThe US Food and Drug Administration (FDA) has approved the first-ever implantable continuous glucose monitoring system, the Eversense CGM (Senseonics) for people aged 18 years and older with diabetes.nnnnThe device consists of a fluorescence-based sensor that is